Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging diagnostics and therapeutics for Alzheimer disease
Wade Self, David M. Holtzman
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2187-2199
Closed Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread
Yun Chen, Sihui Song, Samira Parhizkar, et al.
Cell (2023) Vol. 187, Iss. 2, pp. 428-445.e20
Open Access | Times Cited: 45
Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer’s Disease
Sujun Jiang, Guoen Cai, Zhimin Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 18, pp. 11753-11768
Closed Access | Times Cited: 24
Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank
Xiaofei Wang, Ziyan Shi, Yuhan Qiu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 19
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 19
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Qiuyang Zheng, Xin Wang
Protein & Cell (2024)
Open Access | Times Cited: 19
Radiopharmaceuticals and their applications in medicine
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy
David A. Wolk, Peter T. Nelson, Liana G. Apostolova, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 3
Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis
Sergio Oddi, Lucia Scipioni, Antonio Totaro, et al.
FEBS Journal (2025)
Open Access | Times Cited: 2
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
Jinchao Hou, Yun Chen, Zhangying Cai, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 741
Closed Access | Times Cited: 14
Sex-dependent APOE4 neutrophil–microglia interactions drive cognitive impairment in Alzheimer’s disease
Neta Rosenzweig, Kilian Kleemann, Thomas M. Rust, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2990-3003
Closed Access | Times Cited: 14
Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease
Kathryn A Conn, Emily M. Borsom, Emily K. Cope
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease
Rikesh M. Rajani, Robert Ellingford, Mariam Hellmuth, et al.
PLoS Biology (2024) Vol. 22, Iss. 7, pp. e3002727-e3002727
Open Access | Times Cited: 14
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 12
SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis
Pei Ouyang, Zhiyu Cai, Jiaying Peng, et al.
Redox Biology (2024) Vol. 70, pp. 103064-103064
Open Access | Times Cited: 9
APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APPNL-G-F cerebral organoid model of Alzheimer’s disease
Hang Liu, Fan Mei, Rongrong Ye, et al.
Cell Research (2024) Vol. 34, Iss. 6, pp. 451-454
Closed Access | Times Cited: 8
Association Between Periodontitis and Alzheimer's Disease: A Narrative Review
Mohammad Amin Seyedmoalemi, Zahra Saied-Moallemi
IBRO Neuroscience Reports (2025)
Open Access | Times Cited: 1
The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer’s disease
Shuiyue Quan, Xiaofeng Fu, Huimin Cai, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Dynamic prediction of goal location by coordinated representation of prefrontal-hippocampal theta sequences
Yimeng Wang, Xueling Wang, Ling Wang, et al.
Current Biology (2024) Vol. 34, Iss. 9, pp. 1866-1879.e6
Closed Access | Times Cited: 7
Adaptive immune changes associate with clinical progression of Alzheimer’s disease
Lynn van Olst, Alwin Kamermans, Sem Halters, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Roseburia intestinalis Supplementation Could Reverse the Learning and Memory Impairment and m6A Methylation Modification Decrease Caused by 27-Hydroxycholesterol in Mice
Xuejing Sun, Cui Zhou, Mengwei Ju, et al.
Nutrients (2024) Vol. 16, Iss. 9, pp. 1288-1288
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top